Comparative analysis of three NGS platforms assessing tumor mutational burden and mutational landscape in resectable non-small cell lung cancer

被引：0
|
作者：
Lee, J. B. [1 ]
Choi, S. J. [2 ]
Kim, J. H. [2 ]
Hong, M. H. [1 ]
Cho, B. C. [1 ]
Lim, S. M. [1 ]
机构：
[1] Yonsei Univ, Dept Internal Med, Yonsei Canc Ctr, Div Oncol, Seoul, South Korea
[2] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.10.555
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
481P
引用
收藏
页码：S1649 / S1649
页数：1
相关论文
共 50 条
  • [1] Mutational signature analysis in non-small cell lung cancer patients with a high tumor mutational burden
    van den Heuvel, Guus R. M.
    Kroeze, Leonie I.
    Ligtenberg, Marjolijn J. L.
    Grunberg, Katrien
    Jansen, Erik A. M.
    von Rhein, Daniel
    de Voer, Richarda M.
    van den Heuvel, Michel M.
    RESPIRATORY RESEARCH, 2021, 22 (01)
  • [2] Mutational signature analysis in non-small cell lung cancer patients with a high tumor mutational burden
    Guus R. M. van den Heuvel
    Leonie I. Kroeze
    Marjolijn J. L. Ligtenberg
    Katrien Grünberg
    Erik A. M. Jansen
    Daniel von Rhein
    Richarda M. de Voer
    Michel M. van den Heuvel
    Respiratory Research, 22
  • [3] The clinical utility of tumor mutational burden in non-small cell lung cancer
    Greillier, Laurent
    Tomasini, Pascale
    Barlesi, Fabrice
    TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 (06) : 639 - 646
  • [4] Changes in tumor mutational burden in serially biopsied non-small cell lung cancer
    Smithy, James
    Smithy, James
    Hwang, David
    Li, Yvonne
    Spurr, Liam
    Cherniack, Andrew
    Sholl, Lynette
    Awad, Mark
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [5] Mutational signatures in the perspective of tumour mutational burden in patients with non-small cell lung cancer
    Van den Heuvel, G.
    Kroeze, L.
    Ligtenberg, M.
    Grunberg, K.
    von Rhein, D.
    Jansen, E.
    de Voer, R.
    Van den Heuvel, M.
    ANNALS OF ONCOLOGY, 2020, 31 : S1217 - S1218
  • [6] Mutational landscape of non-small cell lung cancer in the United States
    Elsayed, M. A.
    Allam, A. R.
    KhalafAllah, M. T.
    Aboshady, O.
    Gouda, M. A.
    ANNALS OF ONCOLOGY, 2022, 33 : S1604 - S1605
  • [7] Changes in tumor mutational burden in serially biopsied non-small cell lung cancer.
    Smithy, James W.
    Hwang, David H.
    Li, Yvonne Y.
    Spurr, Liam
    Cherniack, Andrew D.
    Sholl, Lynette M.
    Awad, Mark M.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [8] MiRNAs related to KRAS mutational status in resectable non-small cell lung cancer
    Gallach, S.
    Calabuig-Farinas, S.
    Jantus-Lewintre, E.
    Montaner, D.
    Escorihuela, E.
    Castellano, J.
    Figueroa, S.
    Blasco, A.
    Hernando, C.
    Guijarro, R.
    Camps, C.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 177 - 177
  • [9] Comparison of platforms for determining tumour mutational burden (TMB) in patients with non-small cell lung cancer (NSCLC)
    Baden, J.
    Zhao, C.
    Pratt, J.
    Kirov, S.
    Pant, S.
    Seminara, A.
    Green, G.
    Bilke, S.
    Deras, I.
    Fabrizio, D. A.
    Pawlowski, T.
    ANNALS OF ONCOLOGY, 2019, 30 : 25 - 25
  • [10] Association of tumor mutational burden with smoking and mutation status in non-small cell lung cancer (NSCLC).
    Davis, Andrew A.
    Chae, Young Kwang
    Agte, Sarita
    Pan, Alan
    Mohindra, Nisha Anjali
    Villaflor, Victoria Meucci
    Giles, Francis J.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)
12345